You are here
March 19, 2013
Panel IV: Discussion of HPAI H5N1 GOF Research Case Studies
4:30 -- 6:30 P.M. Panel IV: Discussion of HPAI H5N1 Gain-of-Function Research Case Studies
Presentations of Case Studies:
The panelists will be presented with and discuss case studies that illustrate how the HHS Framework, presented in Panel III, would apply to different HPAI H5N1 GOF research projects.
- How well did the proposed Framework function in the analysis of the case studies? Is it a useful tool for guiding funding decisions?
- Does the Framework appropriately address the range of risks associated with the research?
- Does the Framework provide for the appropriate review of such research?
- Are there gaps that should be addressed by the Framework?
Dennis Dixon, Ph.D.
Chief, Bacteriology and Mycology Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, USA
Amy P. Patterson, M.D.
Associate Director for Science Policy, National Institutes of Health, USA
Tjandra Aditama, M.D.
Director-General, Disease Control and Environmental Health, Ministry of Health, Indonesia
Daniel Altmann, Ph.D. Head of Pathogens, Immunology and Population Health, Wellcome Trust, United Kingdom
Nancy Cox, Ph.D.
Director, Influenza Division, Office of Infectious Diseases, Centers for Disease Control and Prevention, USA
Thomas Inglesby, M.D.
Director, Center for Biosecurity, University of Pittsburgh Medical Center, USA
Joseph Kanabrocki, Ph.D.
Assistant Dean, Biosafety, and Associate Professor of Microbiology, University of Chicago, USA
Yoshihiro Kawaoka, D.V.M., Ph.D.
Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, USA
J. S. Malik Peiris, M.D., Ph.D.
Professor, Centre of Influenza Research and the School of Public Health, The University of Hong Kong, China
Adel Mahmoud, M.D., Ph.D.
Professor, Molecular Biology and Public Policy, Princeton University, USA
Robin Robinson, Ph.D.
Director, Biomedical Advanced Research and Development Authority, Deputy Assistant Secretary for Preparedness and Response, Department of Health and Human Services, USA
This page last reviewed on April 20, 2015